Shortly after making an M&A play to break into the CDMO business, Granules’ manufacturing bona fides have come under fire in a newly published rebuke by the U.S. FDA. In a warning letter dated Feb. 26 ...
Granules India Q2 Results Live : Granules India declared its Q2 results on November 6, 2024, reporting a decline in both topline and profit compared to the same quarter last year. The company ...
The FDA issued Granules India three observations following a recent preapproval inspection at the Indian drugmaker’s U.S. facility. FDA officials inspected the Chantilly, Virginia, plant from Jan. 24 ...
The shares of Granules India crashed over 8 percent on February 28 after the company announced that it has received a warning letter from the US Food and Drug Administration (FDA) for its Gagillapur ...
Nov 13 (Reuters) - Paracetamol maker Granules India (GRAN.NS), opens new tab reported a 34% jump in its second-quarter profit on Thursday, driven by strong demand in its key European and North ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback